Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis

Sansone Alice Capogrosso; Mantarro Stefania; Tuccori Marco; Ruggiero Elisa; Montagnani Sabrina; Convertino Irma; Marino Alessandra; Fornai Matteo; Antonioli Luca; Corona Tiberio; Garibaldi Danila; Blandizzi Corrado

首页> 外文期刊>Drug safety: An international journal of medical toxicology and drug experience >Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis

【24h】

Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis

机译：Certolizumab Pegol在免疫介导的炎性疾病患者中的安全性概况：系统评价和荟萃分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Certolizumab pegol (CZP), an anti-tumor necrosis factor PEGylated Fab' fragment of a humanized monoclonal antibody, is currently approved for treatment of some immune-mediated inflammatory diseases (IMIDs). To our knowledge, no systematic review and meta-analysis evaluating the overall safety profile of CZP has been performed.

机译：Certolizumab pegol（CZP）是人源化单克隆抗体的抗肿瘤坏死因子PEG化Fab'片段，目前已获批准用于治疗某些免疫介导的炎症性疾病（IMID）。据我们所知，尚未进行评估CZP总体安全性的系统评价和荟萃分析。

著录项

来源
《Drug safety: An international journal of medical toxicology and drug experience 》 |2015年第10期| 共20页
作者
Sansone Alice Capogrosso; Mantarro Stefania; Tuccori Marco; Ruggiero Elisa; Montagnani Sabrina; Convertino Irma; Marino Alessandra; Fornai Matteo; Antonioli Luca; Corona Tiberio; Garibaldi Danila; Blandizzi Corrado;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药品 ;
关键词

相似文献

外文文献
中文文献
专利

1. Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis [J] . Sansone Alice Capogrosso, Mantarro Stefania, Tuccori Marco, Drug safety: An international journal of medical toxicology and drug experience . 2015 ,第10期

机译：Certolizumab Pegol在免疫介导的炎性疾病患者中的安全性概况：系统评价和荟萃分析
2. Efficacy and safety of certolizumab pegol for Crohn's disease: A systematic review and meta-analysis [J] . DaW., ZhuJ., WangL., Advances in therapy. . 2013 ,第5期

机译：塞妥珠单抗治疗克罗恩病的疗效和安全性：系统评价和荟萃分析
3. Effect of tofacitinib on cardiovascular events and all-cause mortality in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials [J] . Wenhui Xie, Shiyu Xiao, Yanrong Huang, Therapeutic advances in musculoskeletal disease. . 2019 ,第12期

机译：Tofacitinib对免疫介导的炎症性疾病患者心血管事件和全因死亡率的影响：随机对照试验的系统审查和荟萃分析
4. ORAL CYCLOSPORINE USE IN DOGS IN INFLAMMATORY AND IMMUNE-MEDIATED DISEASES [C] . Todd M. Archer Conference of the American College of Veterinary Internal Medicine . 2014

机译：在炎症和免疫介导的疾病中的狗的口腔环孢菌素使用
5. The Efficacy of Extracorporeal Shock Wave Therapy in Comparison to Low-Level Laser Therapy for Decreasing Pain and Symptom Severity and Increasing Functional Status in Adult Patients with Carpal Tunnel Syndrome: A Systematic Review and Meta-Analysis [D] . Seely, Andrew. 2021

机译：体外冲击波治疗与低水平激光治疗对脑隧道综合征的成人患者疼痛和症状严重程度及函数状况的疗效：系统评价与荟萃分析
6. Correction: Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis [O] . 2012

机译：校正：肥胖和某些免疫介导的炎性疾病患者对抗肿瘤坏死因子-α药物的反应：系统评价和荟萃分析
7. POS1340 MULTICENTER STUDY OF 71 PATIENTS WITH REFRACTORY UVEITIS RELATED TO IMMUNE-MEDIATED INFLAMMATORY DISEASES ON CERTOLIZUMAB PEGOL TREATMENT [O] . J. L. Martín-Varillas, V. Calvo-Río, L. Sanchez-Bilbao, 2021

机译：POS1340对71例难治性葡萄膜炎患者的多中心研究与免疫介导的炎症性疾病对Certolizumab Pegol治疗

Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis

摘要

著录项

相似文献

相关主题

期刊订阅